Imidazo[4,5-d][1,3]diazepin-8(3H)-one, 3-[2-deoxy-3,5-bis-O-(4-methylbenzoyl)-β-D-erythro-pentofuranosyl]-4,7-dihydro-

Imidazo[4,5-d][1,3]diazepin-8(3H)-one, 3-[2-deoxy-3,5-bis-O-(4-methylbenzoyl)-β-D-erythro-pentofuranosyl]-4,7-dihydro- Struktur
72079-79-9
CAS-Nr.
72079-79-9
Englisch Name:
Imidazo[4,5-d][1,3]diazepin-8(3H)-one, 3-[2-deoxy-3,5-bis-O-(4-methylbenzoyl)-β-D-erythro-pentofuranosyl]-4,7-dihydro-
Synonyma:
3-[2-Deoxy-3,5-di-O-para-toluoyl-beta-D-erythro-pentofuranosyl]-6,7-Dihydroimidazo[4,5-d][1,3]diazepin-8(3H)-one;Imidazo[4,5-d][1,3]diazepin-8(3H)-one, 3-[2-deoxy-3,5-bis-O-(4-methylbenzoyl)-β-D-erythro-pentofuranosyl]-4,7-dihydro-
CBNumber:
CB910473880
Summenformel:
C27H26N4O6
Molgewicht:
502.52
MOL-Datei:
72079-79-9.mol

Imidazo[4,5-d][1,3]diazepin-8(3H)-one, 3-[2-deoxy-3,5-bis-O-(4-methylbenzoyl)-β-D-erythro-pentofuranosyl]-4,7-dihydro- Eigenschaften

Siedepunkt:
736.6±70.0 °C(Predicted)
Dichte
1.40±0.1 g/cm3(Predicted)
pka
5.51±0.20(Predicted)

Sicherheit

Imidazo[4,5-d][1,3]diazepin-8(3H)-one, 3-[2-deoxy-3,5-bis-O-(4-methylbenzoyl)-β-D-erythro-pentofuranosyl]-4,7-dihydro- Chemische Eigenschaften,Einsatz,Produktion Methoden

Imidazo[4,5-d][1,3]diazepin-8(3H)-one, 3-[2-deoxy-3,5-bis-O-(4-methylbenzoyl)-β-D-erythro-pentofuranosyl]-4,7-dihydro- Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Imidazo[4,5-d][1,3]diazepin-8(3H)-one, 3-[2-deoxy-3,5-bis-O-(4-methylbenzoyl)-β-D-erythro-pentofuranosyl]-4,7-dihydro- Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 2)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Aktinos Pharma Pvt Ltd --
aktinospharma@aktinos.in India 42 58
Apicore Pharmaceuticals Pvt Ltd --
support@apicore.com India 181 58

  • Imidazo[4,5-d][1,3]diazepin-8(3H)-one, 3-[2-deoxy-3,5-bis-O-(4-methylbenzoyl)-β-D-erythro-pentofuranosyl]-4,7-dihydro-
  • 3-[2-Deoxy-3,5-di-O-para-toluoyl-beta-D-erythro-pentofuranosyl]-6,7-Dihydroimidazo[4,5-d][1,3]diazepin-8(3H)-one
  • 72079-79-9
Copyright 2019 © ChemicalBook. All rights reserved